Tolerability of Saxagliptin in Patients with Inadequately Controlled Type 2 Diabetes: Results from 6 Phase III Studies

por Davidson, Jaime A.
Publicado 2014

Incretin-Based Therapies: Focus on Effects Beyond Glycemic Control Alone

por Davidson, Jaime A.
Publicado 2013

Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview

por Davidson, Jaime A., Sloan, Lance
Publicado 2016

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes

por Davidson, Jaime A., Parkin, Christopher G.
Publicado 2009

Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data

por Davidson, Jaime A., Stager, William, Paranjape, Sachin, Berria, Rachele, Leiter, Lawrence A.
Publicado 2020

Safety of sodium–glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations

por Davidson, Jaime A, Sukor, Norlela, Hew, Fen‐Lee, Mohamed, Mafauzy, Hussein, Zanariah
Publicado 2022

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

por Davidson, Jaime A, Lajara, Rosemarie, Aguilar, Richard B, Mattheus, Michaela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Publicado 2014

Improving access to shared decision-making for Hispanics/Latinos with inadequately controlled type 2 diabetes mellitus

por Davidson, Jaime A, Rosales, Aracely, Shillington, Alicia C, Bailey, Robert A, Kabir, Chris, Umpierrez, Guillermo E
Publicado 2015

Effects of once‐weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials

por Tuttle, Katherine R., McKinney, T. Dwight, Davidson, Jaime A., Anglin, Greg, Harper, Kristine D., Botros, Fady T.
Publicado 2016